FDA Considers Additive to Detox Pig Feed from Sneaky Zearalenone
Published Date: 9/3/2025
Proposed Rule
Summary
Biomin GmbH asked the FDA to approve a new food additive that helps break down a harmful toxin called zearalenone in pig feed. This change aims to keep pigs healthier by reducing this toxin safely. If approved, farmers could start using this additive soon, making pig food safer without extra costs.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Proposal to Allow Enzyme in Swine Feed
The FDA received a petition to allow the enzyme zearalenone hydrolase to be added to swine feed at no less than 10 U/kg of complete feed (U = the five-fold enzymatic activity that hydrolyzes 1 µmol zearalenone per minute in a solution of 5 mg/L zearalenone). If approved, feed makers and pig farmers could legally use this enzyme in pig feed at that specified dose.
Reduces Harmful Zearalenone in Pigs
The petition says the additive helps break down the harmful toxin zearalenone in pig feed and aims to keep pigs healthier by reducing that toxin safely. This change is intended to improve animal health on farms by lowering zearalenone exposure in swine.
No Extra Feed Cost If Approved
The document states that if approved, farmers could start using the additive soon and that it would make pig feed safer without extra costs. That means, according to the petition summary, farmers would not face added feed costs when adopting the enzyme.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16959, Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Frequently asked Questions--Developing Potential Cellular and Gene Therapy Products." The guidance document provides industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy (CGT) products. The FAQs represent common questions directed to the Agency and span multiple disciplines, including regulatory review; chemistry, manufacturing, and controls (CMC); pharmacology/toxicology; clinical; and clinical pharmacology. This guidance announced in this notice finalizes the draft guidance of the same title issued on November 19, 2024.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
Previous / Next Documents
Previous: 2025-16836, State Approving Agency Jurisdiction Rule
The VA is updating rules to clearly explain what counts as independent study, distance learning, and resident learning, plus adding a new term called standard curriculum. This helps State Approving Agencies know exactly which courses they oversee, especially for online classes. These changes affect schools and veterans using education benefits and aim to make things clearer without extra costs or delays.
Next: 2025-16866, Disclosure of Returns and Return Information in Connection With Written Contracts or Agreements for the Acquisition of Property or Services for Tax Administration Purposes; Withdrawal
The government decided to cancel a plan that would have let the State Department share tax info with its contractors to help with passport issues tied to unpaid taxes. This change means no new rules or costs will happen, and people dealing with passport problems won’t see any new info-sharing. Basically, the plan was dropped because it wasn’t needed after all.